22840-2674 : Phoma Betae .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution
| NDC: | 22840-2674 |
| Labeler: | Greer Laboratories, Inc. |
| Product Type: | Non-standardized Allergenic |
| Drug Name: | Phoma Betae |
| Dosage Form: | Intradermal; Percutaneous; Subcutaneous Solution |
| Application #: | BLA101833 |
| Rev. Date: |
NDC Package Codes:
- 22840-2674-2: 10 ML IN 1 VIAL, MULTI‑DOSE (22840‑2674‑2)
Active Ingredients:
- Pleospora Betae
Dosage Strength:
- .05 g/mL
Pharmaceutical Classes:
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Fungal Proteins [CS]
- Allergens [CS]
- Non-Standardized Fungal Allergenic Extract [EPC]
Related Products:
Based on records with the same trade name.- 22840-2618 Phoma Betae .001 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-5632 Phoma Betae .025 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 22840-2673Next: 22840-2675 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
